# Biomat USA Inc. – FDA Inspection, Jul 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f4d57389-921f-46ee-a14d-0b657ffeef85
Source feed: FDA_Inspections

> FDA inspection 1058765 of Biomat USA Inc., July 13, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1058765
- Company Name: Biomat USA Inc.
- Inspection Date: 2018-07-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1172880 - 2022-06-09
- [FDA Inspection 885018 - 2014-06-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/77f26762-4729-460d-a64b-daf9093580b2)
- FDA Inspection 751847 - 2011-10-25
- FDA Inspection 633983 - 2009-12-11

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/nancy-l-neiger/c3209528-eeb3-4a5f-88b1-f503798ed4c5)

Company: https://www.keypedia.com/companies/biomat-usa-inc/4c0b28d9-59f5-4c84-85b8-3f38350d07f9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d